Building High-Touch Patient Supply Chains

By |2021-10-18T10:49:30-04:0010/14/2021|

Life Sciences Supply Chain Working Group Webinar on 10/28 @ 12-1p ET Registration Options I'm already a Supply Chain Working Group Member I am not a Supply Chain Working Group member yet This event will provide insights on emerging methods and practices for designing supply [...]

Biopharmaceutical Supplier Risk Management: What You Need to Know Now

By |2021-10-13T11:12:51-04:0010/13/2021|

The COVID-19 pandemic exposed the risks and fragility inherent in global pharmaceutical and biotechnology supply chains. This isn’t really news though. For some time, these supply chains have lagged other industries in speed, flexibility, agility, redundancy, and diversification. With risk considerations at the forefront resulting from shortages during the pandemic, the US government is [...]

Global Trade Compliance: Why Emerging Biopharmaceutical Company Operations Executives Need to Take Notice

By |2021-09-30T13:18:28-04:0009/27/2021|

Today’s biopharmaceutical supply chains often stretch around the world. Key starting materials (KSM) and API originate more frequently from Asia. Manufacturing is commonly conducted in Europe and North America. And commercial distribution is spread across the globe. This globalization has resulted in increased logistics and global trade compliance (GTC) complexity along with ever-changing import/export [...]

Event Recap: Why is Now the Time for Digital Supply Chain Transformation

By |2021-09-14T11:02:07-04:0009/14/2021|

Clinical supply professionals are responsible for ensuring that patients on clinical trials receive the right drug at the right time for their treatment protocols. The environment is dynamic and challenging, so companies embrace innovation to enable educated and responsible supply decision making. More than ever, biopharmaceutical sponsors are moving towards a digital clinical supply [...]

Improving Clinical Supply Chain Management by Establishing End-to-End Visibility

By |2021-08-09T11:48:14-04:0008/09/2021|

Emerging pharmaceutical companies frequently place responsibility for clinical supply chain management on their clinical operations team and CROs. This approach can work initially for small, resource-constrained organizations. However, it does not help companies build the internal capabilities, knowledge, and resources to successfully run their clinical supply chain over time as they grow. One [...]

Building Supply Chains & Systems for High-Touch Operating Models

By |2021-08-04T13:19:01-04:0008/04/2021|

Converge develops commercial supply chain business processes, commercial systems architecture & last mile strategies. Our client was an emerging pharmaceutical company focused on rare diseases, in clinical trials with an ultra-orphan drug. There were two competitive therapies also in development, so they began preparations for commercial launch on a compressed timeline to [...]

5 Unique Logistics Challenges for Specialty Pharmaceuticals

By |2021-07-29T10:15:32-04:0007/28/2021|

Many of our clients are innovator companies developing novel treatments that are often complex and extremely high value. As a result, they face similar supply chain challenges in preparing for commercialization. Often, these specialty products are also orphan and rare disease treatments, as well as extremely low volume. The supply chains for these emerging [...]

Building Supply Chain Resilience: The Biden Administration’s 100-Day Supply Chain Review Findings on Pharmaceuticals and APIs

By |2021-06-24T11:32:22-04:0006/24/2021|

On February 24, 2021, President Biden signed an Executive Order on America’s Supply Chains (EO) as a step toward building more secure, robust and resilient supply chains. The EO initiated a 100-Day Supply Chain Review, which detailed an assessment of the strengths and weaknesses of the domestic supply chains for four key product areas, one of which included a review of pharmaceuticals and [...]

The CARES Act & Your Supply Chain: What You Need to Know

By |2021-06-24T11:34:46-04:0006/24/2021|

Jeremy Friedler, senior consultant, and Rashi Gupta, consultant, focus on biotechnology and pharmaceutical operations at Converge Consulting. The COVID-19 pandemic and resulting economic crisis exposed the vulnerabilities of both domestic and global supply chains across multiple industries. Given the complexity and far-reaching global nature of their supply chains, pharmaceutical and biotechnology companies were [...]

The CARES Act & Your Supply Chain: What You Need to Know Now

By |2021-06-29T16:04:50-04:0005/19/2021|

Life Sciences Supply Chain Working Group Webinar on June 29 @ 11a-12p Request the Presentation Request the Recording The Coronavirus Aid, Relief, and Economic Security (“CARES”) Act, signed in March 2020, provides emergency assistance and health care response for individuals, families, and businesses affected by the [...]

Go to Top